Enter Domain Name:
continuingstep.net: LOVENOX®(enoxaparin sodium injection) — A Proven Choice with Proven Outcomes
Information about LOVENOX® (enoxaparin sodium injection) for healthcare professionals.

LOVENOX®(enoxaparin sodium injection) — A Proven Choice with Proven Outcomes

Description: Information about LOVENOX® (enoxaparin sodium injection) for healthcare professionals.

Keywords: Lovenox healthcare providers dvt treatment prophylaxis information enoxaparin

Tags: continuingstep, proven, enoxaparin, lovenox®, injection, sodium, outcomes, dvt, choice, information, lovenox, prophylaxis, healthcare, treatment, patients, size, font, homepage, reg, providers, site, professionals, sanofi, aventis, increase, acute, complete, search, surgery, patient, dcsimg, decrease, caregivers, sites, related, redirect, web, medical, coronary, syndrome,

Continuingstep.net

Content Revalency: Title: 77.78%   Description: 80.00%   Keywords: 87.50%  |  Document size: 51,121 bytes
More info: Whois - Trace Route - RBL Check
CONTINUINGSTEP.NET - Site Location
Country/Flag US United States
City/Region/Zip Code , New Jersey,
Organization Aventis Pharmaceuticals
Internet Service Provider Aventis Pharmaceuticals
CONTINUINGSTEP.NET - DNS Information
IP Address 192.234.110.91 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns4.sanofi-synthelabo.com   205.137.77.241
ns2.sanofi-synthelabo.com   193.202.95.241
ns3.sanofi-synthelabo.com   205.137.77.240
ns1.sanofi-synthelabo.com   193.202.95.136
Mail Exchange frasldsuext11.aventis.com   212.121.153.152
Site Response Header
Response HTTP/1.1 301 Moved Permanently
Server Microsoft-IIS/6.0
Date Sun, 10 Apr 2011 11:12:04 GMT
Content-Type text/html; charset=utf-8
Cookie ASP.NET_SessionId=ruatfkvvrlrkspaqki0kc245; path=/; HttpOnly